Left Menu
Development News Edition

Researchers developing cannabis-based drugs for use in India

Devdiscourse News Desk | New Delhi | Updated: 23-11-2018 19:33 IST | Created: 23-11-2018 19:10 IST
Researchers developing cannabis-based drugs for use in India

The Council of Scientific and Industrial Research (CSIR) is doing a research on the medicinal use of cannabis for treating diseases like cancer, epilepsy and sickle cell anaemia.

"We have got a license from the Jammu and Kashmir government for conducting the research programme. We have already started it and will soon meet the Drug Controller General of India (DCGI) for approval of use of cannabis as drugs for trial on humans," Ram Vishwakarma, Director, CSIR-IIIM (Indian Institute of Integrative Medicine) told the media here on Friday.

In April 2017, the Centre and the Ministry of Health and Welfare issued a research licence to grow cannabis to the CSIR-IIIM in collaboration with Bombay Hemp Company (BOHECO).

To carry ahead the research programme on a larger scale, CSIR has also joined hands with Indian Council of Medical Research (ICMR) and Department of Biotechnology (DBT), under Ministry of Science and Technology.

"CSIR will primarily conduct the research part while ICMR will provide medical experts. These sort of research projects require good funding and therefore the finance part will be taken care of by DBT," he added.

For the research, CSIR has selected a certain variety of cannabis plants like THC and CBC which are a class of compounds known as cannabinoids, found in abundance in the cannabis plant.

"Not all cannabis plants can be used for medical purpose. We have already started collecting and cultivating selected breed of cannabis. Trials are also being conducted on animals and once it is completed, we will place it for DCGI's approval," Vishwakarma said.

The CSIR-IIIM Director further said that on the primary basis, the impact of the drugs procured from cannabis will be conducted first in Tata Memorial Hospital, Mumbai.

"AIIMS have also agreed along with NIMHANS and Sickle Cell Institute Raipur, Chattisgarh. We would certainly want more medical institutes to join in the process so that the benefit of cannabis on health can be known," Vishwakarma said.

Vivek Benegal, Professor, Centre for Addiction Medicine, NIMHANS said that some early studies have explored the beneficial effects of cannabidiol on persons addicted to opioids like heroin, alcohol and even tobacco.

"This chemical will have useful applications in the treatment of addictive disorders. But before that, the molecule must be subject to stringent and scientifically rigorous testing. This is difficult due to its current ambiguous position under the law in India, especially the Narcotic Drugs and Psychotropic Substances Act," Benegal added.



Canada’s COVID-19 pitfalls highlight need for integrated health information system

In the globalized world of today where outbreaks can spread far and wide within a matter of days, a global-level integrated health information system is ideal but Canadas provincial barriers show that the country lags much behind in deployi...

Pandemic must be impetus, not obstacle, for clean water access

To make matters worse, there are suspicions that the inadequacy of wastewater treatment methods in California, the rest of the USA, and indeed around the world may help to propagate the disease even more widely. ...

3D printing and the future of manufacturing post COVID-19

The on-demand, customizable, and localized manufacturing of product components facilitated by 3D printing has the potential to redefine manufacturing but there are certain technical, mechanical, and legal limitations that, unless ...

How UK’s 'best prepared' healthcare system failed to gauge COVID-19

The UK is proud of their public health system and its unlike any other country as around 90 percent of British public supports the founding principles of National Health Service. But without accurate data being available to stakeholders in ...


Latest News

FACTBOX-Who is speaking at the Democratic National Convention - and why

Next weeks Democratic National Convention will feature a lineup of heavyweight politicians, rising stars and everyday Americans making the case for why Joe Biden should be elected U.S. president on Nov. 3. Here is a look at the speakers who...

U.S. inks $1.5 billion deal with Moderna for 100 million doses of COVID-19 vaccine

The United States has entered an agreement with drugmaker Moderna Inc to acquire 100 million doses of its potential COVID-19 vaccine for around 1.5 billion, the company and White House said on Tuesday. The United States in recent weeks has ...

Brazil's Bolsonaro calls surging Amazon fires a 'lie'

Brazils President Jair Bolsonaro on Tuesday angrily denied the existence of fires in the Amazon rainforest, calling it a lie, despite data produced by his own government showing that thousands of fires are surging across the region.Bolsonar...

US revises UN resolution to extend UN arms embargo on Iran

The United States on Tuesday circulated a revised resolution that would extend a UN arms embargo on Iran indefinitely, seeking to gain more support in the 15-member Security Council where veto-wielding Russia and China have voiced strong op...

Give Feedback